Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
6(33%)
Results Posted
20%(1 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_1
1
6%
Ph phase_2
1
6%
Ph phase_3
1
6%
Ph not_applicable
12
67%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
1(6.7%)
N/ANon-phased studies
12(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

6

trials recruiting

Total Trials

18

all time

Status Distribution
Active(7)
Completed(5)
Terminated(1)
Other(5)

Detailed Status

Recruiting6
Completed5
unknown5
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
6
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (6.7%)
Phase 21 (6.7%)
Phase 31 (6.7%)
N/A12 (80.0%)

Trials by Status

terminated16%
completed528%
not_yet_recruiting16%
recruiting633%
unknown528%

Recent Activity

6 active trials
Showing 5 of 18
recruitingnot_applicable

Ablative Technique For Ovarian Preservation In Endometrioma

NCT07119060
recruiting

Caprini Score in Venous Surgery: a Prospective Cohort Study

NCT03041805
recruitingnot_applicable

Endometrioma Sclerotherapy and Ovarian Preservation

NCT06775769
recruiting

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

NCT06971458
recruitingnot_applicable

Laser Treatment of Reticular Leg Veins Vs. Sclerotherapy

NCT06175754
View all 18 trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07119060Not Applicable

Ablative Technique For Ovarian Preservation In Endometrioma

Recruiting
NCT03041805

Caprini Score in Venous Surgery: a Prospective Cohort Study

Recruiting
NCT06775769Not Applicable

Endometrioma Sclerotherapy and Ovarian Preservation

Recruiting
NCT06971458

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

Recruiting
NCT06175754Not Applicable

Laser Treatment of Reticular Leg Veins Vs. Sclerotherapy

Recruiting
NCT06639230Not Applicable

Effect of Laser and Sclerotic Agent in the Treatment of Oral Granuloma

Not Yet Recruiting
NCT06399744Not Applicable

Role of Sclerotherapy in Treatment of Non-neoplastic Ovarian Cyst

Completed
NCT03035747

Ongoing Registry of Treatment of Chronic Venous Diseases

Recruiting
NCT04132323Not Applicable

Low Concentrate Detergents Versus Hypertonic Glucose for the Treatment of Telangiectasia

Completed
NCT03571776Not Applicable

Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial

Terminated
NCT05228054Not Applicable

Treatment of Hemorrhoid With 1940nm Laser Procedure

Unknown
NCT01408732Phase 1

Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia

Completed
NCT02646202Phase 3

Scleroligation for Eradication of Gastroesophageal Varices.

Unknown
NCT02082613Not Applicable

Lord´s Procedure Versus Sclerotherapy for Testicular Hydrocele; a Randomized Controlled Study

Unknown
NCT01118390Not Applicable

Treatment of Leg Telangiectasias With Nd:YAG 1064nm

Unknown
NCT00835939Phase 2

Treatment for Achilles Tendinopathy

Unknown
NCT00820781Not Applicable

Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices

Completed
NCT00639899Not Applicable

The Effect of Spermatic Vein Embolization on Prostatic Hypertrophy

Completed

All 18 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
18